Exercise-induced GPLD1 is associated with neuroprotection and improvement of hippocampal dysfunction in an Alzheimer's disease model [0.03%]
运动诱导GPLD1与阿尔茨海默病模型中神经保护及海马功能障碍改善相关性研究
Muaz Belviranlı,Nilsel Okudan,Tuğba Sezer
Muaz Belviranlı
This study investigated the therapeutic potential of exercise training and the associated role of Glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) in an experimental Alzheimer’s disease (AD) model. Using a D-galactose/AlCl3 i...
Enhanced combined effect of thymoquinone and transcranial photobiomodulation on cerebral ischemia-induced injuries in animal model [0.03%]
改良品异硫氰酸茋醌联合经颅光生物调节对动物缺血性卒中损伤的协同保护作用研究
Zohre Fendereski Jaz,Mohammadreza Bigdeli,Sepideh Khaksar et al.
Zohre Fendereski Jaz et al.
Cerebrospinal fluid glucose levels and their association with disability, depression, and cognitive function in multiple sclerosis [0.03%]
多发性硬化患者脑脊液血糖水平及其与残疾、抑郁和认知功能的关系
Lilith Hauck,Carolin Franz,Kimberly Koerbel et al.
Lilith Hauck et al.
Glucose dysregulation in the CNS contributes to both inflammation and neurodegeneration in multiple sclerosis (MS). While glucose levels are routinely measured in peripheral blood, these levels do not necessarily reflect glucose levels in t...
Association of Wnt1, PORCN, RSPO2 and neuroinflammation with cognitive impairment, depression and quality of life in type 2 diabetes mellitus: a case-control study [0.03%]
WNT1、PORCN、RSPO2和神经炎症与2型糖尿病患者认知功能障碍、抑郁及相关生活质量的关系：一项病例对照研究
Atiya Sahar,Haya Majid,Mansi Dahalia et al.
Atiya Sahar et al.
Placental dysfunction, inflammation, and impaired autophagy in preeclampsia: A pathophysiological link to autism spectrum disorder [0.03%]
胎盘功能障碍、炎症和自噬损伤在子痫前期中的病理生理作用与谱系自闭症的关系
Anass M Abbas,Hayder M Al-Kuraishy,Al-Maiahy Thabat J et al.
Anass M Abbas et al.
Vascular endothelial growth factor (VEGF)-related blood flow regulation and anti-inflammation in the protection of Danzhu Fuyuan Granules against cognitive impairment [0.03%]
丹栀复元颗粒通过血管内皮生长因子(VEGF)相关调控脑血流和抗炎作用保护认知障碍
Yu Duan,De-Wei Zhu,Qin Liu et al.
Yu Duan et al.
Pharmacological evaluation of Lonafarnib in reversing neurobehavioral, neurochemical and metabolic deficit in mouse models of chronic unpredictable mild stress (CUMS) [0.03%]
药物评估Lonafarnib在逆转慢性轻度不可预测应激小鼠模型神经行为、神经化学和代谢缺陷中的作用
Vivek Kumar Sharma,Shareen Singh,Amritpal Kaur et al.
Vivek Kumar Sharma et al.
Chronic Unpredictable Mild Stress (CUMS) is a well-established model for inducing behavioral, cognitive, neurochemical, and metabolic impairments associated with neurobehavioral alterations. This study assessed the neuroprotective, antidepr...
Peptide-based therapeutics in the management of Alzheimer's disease (AD) and their potential to develop novel strategies [0.03%]
肽基治疗剂在阿尔茨海默病（AD）管理中的应用及其开发新型策略的潜力
Showkat Ul Nabi,Iyman Rasool,Andleeb Khan et al.
Showkat Ul Nabi et al.
The role of 2-Oxoglutarate dehydrogenase complex mitochondrial enzyme in alzheimer's disease: a literature review and bioinformatics workflow [0.03%]
天冬氨酸脱羧酶复合物线粒体酶在阿尔茨海默病中的作用：文献综述与生物信息学工作流程
Fatemeh Sayehmiri,Mohanna Parvenous,Kimia Vakili et al.
Fatemeh Sayehmiri et al.
Epitranscriptomic and immunometabolic mechanisms of traditional Chinese medicine in metabolic-associated cognitive impairment: a narrative review [0.03%]
基于表观转录组和免疫代谢的中医药防治代谢相关性认知障碍的作用机制研究进展
Chengxia Kan,Guoli Zhang,Wei Liu
Chengxia Kan